Kelly Lawrence W & Associates Inc Johnson & Johnson Transaction History

Kelly Lawrence W & Associates Inc

$430 Million
Q3 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 62,353 shares of JNJ stock, worth $9.71 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares

62,353

Previous 62,584 0.37%

Holding current value

$9.71 Million

Previous $9.15 Million 10.46%

% of portfolio

2.35%

Previous 2.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $33,605 - $38,664	-231 Reduced 0.37%	62,353 $10.1 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $465,336 - $508,524	-3,223 Reduced 4.9%	62,584 $9.15 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $428,096 - $448,836	-2,758 Reduced 4.02%	65,807 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $294,112 - $320,937	-2,020 Reduced 2.86%	68,565 $10.7 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $36,445 - $40,828	-234 Reduced 0.33%	70,585 $11 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $194,172 - $208,966	-1,258 Reduced 1.75%	70,819 $11.7 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $83,983 - $100,224	-556 Reduced 0.77%	72,077 $11.2 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.19 Million - $1.34 Million	-7,431 Reduced 9.28%	72,633 $12.8 Million
Q3 2022 Nov 15, 2022	SELL	$161.33 - $179.52 $104,057 - $115,790	-645 Reduced 0.8%	80,064 $13.1 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $99,904 - $110,489	-594 Reduced 0.73%	80,709 $14.3 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $11,069 - $12,571	70 Added 0.09%	81,303 $14.4 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $129,889 - $144,117	-833 Reduced 1.02%	81,233 $13.9 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $11,305 - $12,562	70 Added 0.09%	82,066 $13.3 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $72,563 - $77,836	455 Added 0.56%	81,996 $13.5 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $4.27 Million - $4.75 Million	27,868 Added 51.92%	81,541 $13.4 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $4.06 Million - $4.66 Million	-29,628 Reduced 35.57%	53,673 $8.45 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $5.88 Million - $6.44 Million	-41,883 Reduced 33.46%	83,301 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $53,713 - $64,847	-417 Reduced 0.33%	125,184 $17.6 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $1.15 Million - $1.59 Million	-10,350 Reduced 7.61%	125,601 $16.5 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $75,862 - $87,131	-595 Reduced 0.44%	135,951 $19.8 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $74,900 - $83,862	-590 Reduced 0.43%	136,546 $17.7 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $89,837 - $98,804	685 Added 0.5%	137,136 $19.1 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $160,921 - $178,931	-1,280 Reduced 0.93%	136,451 $19.1 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $536,073 - $645,173	-4,364 Reduced 3.07%	137,731 $17.8 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $195,743 - $230,036	1,610 Added 1.15%	142,095 $19.6 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $20,895 - $23,058	175 Added 0.12%	140,485 $17 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $85,068 - $100,735	-680 Reduced 0.48%	140,310 $18 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $1.3 Million - $1.43 Million	9,942 Added 7.59%	140,990 $19.7 Million
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $17 Million - $17.7 Million	131,048	131,048 $17 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $407B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Account

Kelly Lawrence W & Associates Inc Johnson & Johnson Transaction History